|
1
|
El-Serag HB and Rudolph KL: Hepatocellular
carcinoma: Epidemiology and molecular carcinogenesis.
Gastroenterology. 132:2557–2576. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Han YF, Zhao J, Ma LY, Yin JH, Chang WJ,
Zhang HW and Cao GW: Factors predicting occurrence and prognosis of
hepatitis-B-virus-related hepatocellular carcinoma. World J
Gastroenterol. 17:4258–4270. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Engelke M, Mills K, Seitz S, Simon P,
Gripon P, Schnölzer M and Urban S: Characterization of a hepatitis
B and hepatitis delta virus receptor binding site. Hepatology.
43:750–760. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lu L, Li Y, Kim SM, Bossuyt W, Liu P, Qiu
Q, Wang Y, Halder G, Finegold MJ, Lee JS and Johnson RL: Hippo
signaling is a potent in vivo growth and tumor suppressor pathway
in the mammalian liver. Proc Natl Acad Sci USA. 107:1437–1442.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu AM, Xu MZ, Chen J, Poon RT and Luk JM:
Targeting YAP and Hippo signaling pathway in liver cancer. Expert
Opin Ther Targets. 14:855–868. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Komuro A, Nagai M, Navin NE and Sudol M:
WW domain-containing protein YAP associates with ErbB-4 and acts as
a co-transcriptional activator for the carboxyl-terminal fragment
of ErbB-4 that translocates to the nucleus. J Biol Chem.
278:33334–33341. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zaidi SK, Sullivan AJ, Medina R, Ito Y,
van Wijnen AJ, Stein JL, Lian JB and Stein GS: Tyrosine
phosphorylation controls Runx2-mediated subnuclear targeting of YAP
to repress transcription. EMBO J. 23:790–799. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lapi E, Di Agostino S, Donzelli S, Gal H,
Domany E, Rechavi G, Pandolfi PP, Givol D, Strano S, Lu X and
Blandino G: PML, YAP and p73 are components of a proapoptotic
autoregulatory feedback loop. Mol Cell. 32:803–814. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhao B, Ye X, Yu J, Li L, Li W, Li S, Yu
J, Lin JD, Wang CY, Chinnaiyan AM, et al: TEAD mediates
YAP-dependent gene induction and growth control. Genes Dev.
22:1962–1971. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dong J, Feldmann G, Huang J, Wu S, Zhang
N, Comerford SA, Gayyed MF, Anders RA, Maitra A and Pan D:
Elucidation of a universal size-control mechanism in Drosophila and
mammals. Cell. 130:1120–1133. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kowalik MA, Saliba C, Pibiri M, Perra A,
Ledda-Columbano GM, Sarotto I, Ghiso E, Giordano S and Columbano A:
Yes-associated protein regulation of adaptive liver enlargement and
hepatocellular carcinoma development in mice. Hepatology.
53:2086–2096. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Overholtzer M, Zhang J, Smolen GA, Muir B,
Li W, Sgroi DC, Deng CX, Brugge JS and Haber DA: Transforming
properties of YAP, a candidate oncogene on the chromosome 11q22
amplicon. Proc Natl Acad Sci USA. 103:12405–12410. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhao B, Wei X, Li W, Udan RS, Yang Q, Kim
J, Xie J, Ikenoue T, Yu J, Li L, et al: Inactivation of YAP
oncoprotein by the Hippo pathway is involved in cell contact
inhibition and tissue growth control. Genes Dev. 21:2747–2761.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Steinhardt AA, Gayyed MF, Klein AP, Dong
J, Maitra A, Pan D, Montgomery EA and Anders RA: Expression of
Yes-associated protein in common solid tumors. Hum Pathol.
39:1582–1589. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Muramatsu T, Imoto I, Matsui T, Kozaki K,
Haruki S, Sudol M, Shimada Y, Tsuda H, Kawano T and Inazawa J: YAP
is a candidate oncogene for esophageal squamous cell carcinoma.
Carcinogenesis. 32:389–398. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xu MZ, Yao TJ, Lee NP, Ng IO, Chan YT,
Zender L, Lowe SW, Poon RT and Luk JM: Yes-associated protein is an
independent prognostic marker in hepatocellular carcinoma. Cancer.
115:4576–4585. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang T, Zhang J, You X, Liu Q, Du Y, Gao
Y, Shan C, Kong G, Wang Y, Yang X, Ye L and Zhang X: Hepatitis B
virus X protein modulates oncogene Yes-associated protein by CREB
to promote growth of hepatoma cells. Hepatology. 56:2051–2059.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tang H, Oishi N, Kaneko S and Murakami S:
Molecular functions and biological roles of hepatitis B virus ×
protein. Cancer Sci. 97:977–983. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ng SA and Lee C: Hepatitis B virus X gene
and hepatocarcinogenesis. J Gastroenterol. 46:974–990. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang X, Zhang H and Ye L: Effects of
hepatitis B virus X protein on the development of liver cancer. J
Lab Clin Med. 147:58–66. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Llovet JM, Di Bisceglie AM, Bruix J,
Kramer BS, Lencioni R, Zhu AX, Sherman M, Schwartz M, Lotze M,
Talwalkar J and Gores GJ: Panel of Experts in HCC-Design Clinical
Trials: Design and endpoints of clinical trials in hepatocellular
carcinoma. J Natl Cancer Inst. 100:698–711. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ji JF and Ma XH: Effect of baculovirus P35
protein on apoptosis in brain tissue of rats with acute cerebral
infarction. Genet Mol Res. 14:9353–9360. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang JH, Li XJ, Chai SJ and Wang XY:
Neuroprotective effect and its mechanism of lentivirus mediated
VEGF on rat model with cerebral ischemic injury. Int J Clin Exp
Med. 8:4094–4100. 2015.PubMed/NCBI
|
|
24
|
Wang Y, Lu Y, Toh ST, Sung WK, Tan P, Chow
P, Chung AY, Jooi LL and Lee CG: Lethal-7 is down-regulated by the
hepatitis B virus × protein and targets signal transducer and
activator of transcription 3. J Hepatol. 53:57–66. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen JY, Chen YJ, Yen CJ, Chen WS and
Huang WC: HBx sensitizes hepatocellular carcinoma cells to
lapatinib by up-regulating ErbB3. Oncotarget. 7:473–489.
2016.PubMed/NCBI
|
|
26
|
Sung WK, Lu Y, Lee CW, Zhang D, Ronaghi M
and Lee CG: Deregulated direct targets of the hepatitis B virus
(HBV) protein, HBx, identified through chromatin
immunoprecipitation and expression microarray profiling. J Biol
Chem. 284:21941–21954. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhou D, Conrad C, Xia F, Park JS, Payer B,
Yin Y, Lauwers GY, Thasler W, Lee JT, Avruch J and Bardeesy N: Mst1
and Mst2 maintain hepatocyte quiescence and suppress hepatocellular
carcinoma development through inactivation of the Yap1 oncogene.
Cancer Cell. 16:425–438. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu G, Yu FX, Kim YC, Meng Z, Naipauer J,
Looney DJ, Liu X, Gutkind JS, Mesri EA and Guan KL: Kaposi
sarcoma-associated herpesvirus promotes tumorigenesis by modulating
the Hippo pathway. Oncogene. 34:3536–3546. 2015. View Article : Google Scholar : PubMed/NCBI
|
